HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Charles Delchier Selected Research

Therapeutics

3/202414-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open-label randomized noninferiority controlled trial.
9/2017Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.
2/2016Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
3/2011Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
2/2010Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.
9/2009Helicobacter pylori and non-malignant diseases.
2/2009Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.
9/2008[Helicobacter pylori infection: what to do after first intent treatment failure?].
2/2002Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Charles Delchier Research Topics

Disease

9Infections
03/2024 - 10/2003
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2017 - 01/2006
6Lymphoma (Lymphomas)
05/2013 - 08/2005
4Neoplasms (Cancer)
09/2017 - 03/2008
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2016 - 04/2013
2Ulcerative Colitis
12/2012 - 11/2003
2Atrophy
03/2008 - 08/2006
2Crohn Disease (Crohn's Disease)
02/2006 - 01/2006
1Lymphatic Metastasis
09/2017
1Dysbiosis
01/2014
1Colorectal Neoplasms (Colorectal Cancer)
01/2014
1Carcinogenesis
06/2012
1Peptic Ulcer (Peptic Ulcers)
09/2009
1Gastritis
09/2009
1Polyps
09/2009
1Gastroesophageal Reflux (GERD)
09/2009
1Dyspepsia (Indigestion)
09/2009
1Duodenal Ulcer (Curling's Ulcer)
06/2009
1Liver Diseases (Liver Disease)
07/2008
1Stomach Neoplasms (Stomach Cancer)
03/2008
1Metaplasia
08/2006
1Rheumatoid Arthritis
01/2006
1Necrosis
01/2006
1Spondylarthropathies
01/2006
1Latent Tuberculosis
01/2006
1Familial primary gastric lymphoma
08/2005
1Renal Cell Carcinoma (Grawitz Tumor)
10/2004
1Neoplasm Metastasis (Metastasis)
10/2004
1Ankylosing Spondylitis
11/2003
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2002

Drug/Important Bio-Agent (IBA)

4Infliximab (Remicade)FDA Link
02/2016 - 02/2006
3Amoxicillin (Wymox)FDA LinkGeneric
03/2024 - 09/2008
3Chlorambucil (Leukeran)FDA Link
05/2013 - 02/2009
2Tetracycline (Achromycin)FDA LinkGeneric
09/2016 - 03/2011
2Metronidazole (Metric)FDA LinkGeneric
09/2016 - 03/2011
2PotassiumIBA
09/2016 - 03/2011
2bismuth tripotassium dicitrate (bismuth subcitrate)IBA
09/2016 - 03/2011
2Omeprazole (Prilosec)FDA LinkGeneric
09/2016 - 03/2011
2Biomarkers (Surrogate Marker)IBA
01/2014 - 06/2009
2Rituximab (Mabthera)FDA Link
05/2013 - 02/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2013 - 01/2006
2Clarithromycin (Biaxin)FDA LinkGeneric
03/2011 - 09/2008
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2009 - 11/2003
2Alkylating AgentsIBA
08/2006 - 08/2005
1Esomeprazole (Nexium)FDA Link
03/2024
1GuaiacIBA
01/2014
1Monoclonal AntibodiesIBA
04/2013
1SteroidsIBA
12/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2012
1NADPH Oxidases (NAD(P)H oxidase)IBA
06/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2012
1Capsules (Microcapsules)IBA
03/2011
1Genetic Markers (Genetic Marker)IBA
06/2010
1DNA (Deoxyribonucleic Acid)IBA
06/2010
1Virulence Factors (Pathogenicity Factors)IBA
06/2010
1A-factor (Streptomyces)IBA
02/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2009
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2003
1Urea (Carbamide)FDA LinkGeneric
10/2003

Therapy/Procedure

9Therapeutics
03/2024 - 02/2002
5Drug Therapy (Chemotherapy)
09/2017 - 08/2005
2Gastrectomy
07/2008 - 03/2008
2Conservative Treatment
08/2006 - 02/2002
1Colectomy
12/2012
1Nephrectomy
10/2004